A new, in-depth market report by Credence Research reveals that the Global Food Can Coatings Market is undergoing a ...

The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.

The U.S. Department of Housing and Urban Development’s (HUD) 2025 Innovative Housing Showcase returned to the National Mall in Washington, D.C. from September 6–10. Themed “The American Home is the ...

The FDA approved a generic version of the abortion drug mifepristone produced by Evita Solutions, according to an agency letter dated Sept. 30. On its website, Evita states its mission is to assist ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological ...

Let me be straight with you right from the start—if you've been hiding your smile in photos, covering your mouth when you laugh, or avoiding social situations because of your teeth, I get it. I've ...

More than 10 years after bringing one of the first idiopathic pulmonary fibrosis (IPF) drugs to market, Boehringer Ingelheim is freshening up its leadership in the rare lung disease space with a newly ...

ZORYVE cream 0.05% provides rapid and effective relief of mild to moderate atopic dermatitis in children ages 2 to 5 and is safe and well tolerated Once-daily, steroid-free cream can be used anywhere ...

Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB) Breakthrough Therapy ...